ConductScience.org, home

Gene · 5499

Papers4,146

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

241 to 260 of 4,146

Download this page as JSON
TitleJournalYearPMIDFound bySource
Towards Understanding Long COVID: SARS-CoV-2 Strikes the Host Cell Nucleus.Pathogens202337375496PubTator, text miningPubMed
Comprehensive Understanding of the Kinetic Behaviors of Main Protease from SARS-CoV-2 and SARS-CoV: New Data and Comparison to Published Parameters.Molecules202337375160PubTator, text miningPubMed
Interferon at the crossroads of SARS-CoV-2 infection and COVID-19 disease.J Biol Chem202337364688PubTator, text miningPubMed
Drug target of natural products and COVID-19: how far has science progressed?Ann Med Surg (Lond)202337363478PubTator, text miningPubMed
Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 helicase inhibitors: a systematic review of invitro studies.J Virus Erad202337363132PubTator, text miningPubMed
More than a key-the pathological roles of SARS-CoV-2 spike protein in COVID-19 related cardiac injury.Sports Med Health Sci202337361919PubTator, text miningPubMed
Reverse Genetic Assessment of the Roles Played by the Spike Protein and ORF3 in Porcine Epidemic Diarrhea Virus Pathogenicity.J Virol202337358450PubTator, text miningPubMed
Crystal structures of main proteases of SARS-CoV-2 variants bound to a benzothiazole-based inhibitor.Acta Biochim Biophys Sin (Shanghai)202337357528PubTator, text miningPubMed
A mutation in the coronavirus nsp13-helicase impairs enzymatic activity and confers partial remdesivir resistance.mBio202337338298PubTator, text miningPubMed
FlipGFP protease assay for evaluating in vitro inhibitory activity against SARS-CoV-2 Mpro and PLpro.STAR Protoc202337329507PubTator, text miningPubMed
Role and clinical implication of autophagy in COVID-19.Virol J202337328875PubTator, text miningPubMed
Regulation of PKR-dependent RNA translation inhibition by TRIM21 upon virus infection or other stress.PLoS Pathog202337327222PubTator, text miningPubMed
Diagnostics and analysis of SARS-CoV-2: current status, recent advances, challenges and perspectives.Chem Sci202337325147PubTator, text miningPubMed
Combining virtual screening with cis-/trans-cleavage enzymatic assays effectively reveals broad-spectrum inhibitors that target the main proteases of SARS-CoV-2 and MERS-CoV.Antiviral Res202337321487PubTator, text miningPubMed
Harnessing aptamers against COVID-19: A therapeutic strategy.Drug Discov Today202337315763PubTator, text miningPubMed
COVID-19 Therapeutic Potential of Natural Products.Int J Mol Sci202337298539PubTator, text miningPubMed
SARS-CoV-2 Evasion of the Interferon System: Can We Restore Its Effectiveness?Int J Mol Sci202337298304PubTator, text miningPubMed
Elucidation of novel compounds and epitope-based peptide vaccine design against C30 endopeptidase regions of SARS-CoV-2 using immunoinformatics approaches.Front Cell Infect Microbiol202337293206PubTator, text miningPubMed
The GCN2/eIF2αK stress kinase regulates PP1 to ensure mitotic fidelity.EMBO Rep202337291955PubTator, text miningPubMed
Swine acute diarrhoea syndrome coronavirus (SADS-CoV) Nsp5 antagonizes type I interferon signaling by cleaving DCP1A.Front Immunol202337283741PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/5499/papers?page=13